Iovance Biotherapeutics Inc (IOVA)
11.66
+0.20
(+1.70%)
USD |
NASDAQ |
Nov 05, 16:00
11.59
-0.06
(-0.56%)
After-Hours: 16:14
Iovance Biotherapeutics Enterprise Value: 3.067B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 3.067B |
| November 01, 2024 | 2.985B |
| October 31, 2024 | 2.757B |
| October 30, 2024 | 2.939B |
| October 29, 2024 | 2.869B |
| October 28, 2024 | 2.936B |
| October 25, 2024 | 2.827B |
| October 24, 2024 | 2.794B |
| October 23, 2024 | 2.569B |
| October 22, 2024 | 2.611B |
| October 21, 2024 | 2.599B |
| October 18, 2024 | 2.696B |
| October 17, 2024 | 2.675B |
| October 16, 2024 | 2.432B |
| October 15, 2024 | 2.499B |
| October 14, 2024 | 2.554B |
| October 11, 2024 | 2.545B |
| October 10, 2024 | 2.463B |
| October 09, 2024 | 2.505B |
| October 08, 2024 | 2.539B |
| October 07, 2024 | 2.621B |
| October 04, 2024 | 2.763B |
| October 03, 2024 | 2.551B |
| October 02, 2024 | 2.551B |
| October 01, 2024 | 2.426B |
| Date | Value |
|---|---|
| September 30, 2024 | 2.438B |
| September 27, 2024 | 2.505B |
| September 26, 2024 | 2.396B |
| September 25, 2024 | 2.387B |
| September 24, 2024 | 2.423B |
| September 23, 2024 | 2.520B |
| September 20, 2024 | 2.669B |
| September 19, 2024 | 2.730B |
| September 18, 2024 | 2.675B |
| September 17, 2024 | 2.751B |
| September 16, 2024 | 2.566B |
| September 13, 2024 | 2.727B |
| September 12, 2024 | 2.460B |
| September 11, 2024 | 2.426B |
| September 10, 2024 | 2.375B |
| September 09, 2024 | 2.581B |
| September 06, 2024 | 2.627B |
| September 05, 2024 | 2.763B |
| September 04, 2024 | 2.769B |
| September 03, 2024 | 2.882B |
| August 30, 2024 | 3.127B |
| August 29, 2024 | 3.042B |
| August 28, 2024 | 3.027B |
| August 27, 2024 | 3.049B |
| August 26, 2024 | 3.200B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
483.88M
Minimum
Oct 19 2023
7.095B
Maximum
Feb 08 2021
2.569B
Average
2.426B
Median
Sep 11 2024
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 530.78M |
| Electromed Inc | 180.63M |
| Xtant Medical Holdings Inc | 101.94M |
| Myomo Inc | 106.78M |
| Catheter Precision Inc | 2.064M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -97.10M |
| Revenue (Quarterly) | 31.11M |
| Total Expenses (Quarterly) | 133.02M |
| EPS Diluted (Quarterly) | -0.34 |
| Gross Profit Margin (Quarterly) | -0.84% |
| Profit Margin (Quarterly) | -312.2% |
| Earnings Yield | -14.33% |
| Normalized Earnings Yield | -14.33 |